Skip to main content
. 2020 Mar 2;4(5):815–818. doi: 10.1182/bloodadvances.2019001215

Figure 1.

Figure 1.

Platelet count trends and immunohistochemistry staining. (A) Patient’s platelet count after ITP treatment (including daratumumab) and transfusion needs. (B) CD138 immunohistochemical staining showed increased plasma cells in a spleen section.